PDE5A and colorectal carcinoma: Thus we explored the therapeutic potential of PDE5 inhibitors in a retrospective cohort of patients with CRC, and we find that post-diagnostic use of PDE5 inhibitors could significantly reduce the subsequent development of metastasis as well as the risk of death due to CRC.